|Bid||67.51 x 2200|
|Ask||67.37 x 1300|
|Day's range||66.63 - 67.40|
|52-week range||53.63 - 71.70|
|Beta (5Y monthly)||0.12|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||1.44 (2.15%)|
|Ex-dividend date||24 Feb 2022|
|1y target est||71.80|
Over the past six months, the market has fallen sharply thanks to a toxic combination of fears about a looming recession, rising inflation, and rising interest rates. Growth stocks and unprofitable companies have been especially hard hit. Sanofi (NASDAQ: SNY) is a multinational pharma giant with a market cap in excess of $135 billion, and its shares are up by over 17% from six months ago.
European Commission authorizes a booster dose of AstraZeneca's (AZN) COVID-19 vaccine and approves Merck (MRK) and Roche's (RHHBY) oncology drugs for expanded use.
WILMINGTON, Del., May 27, 2022--The first patients have been dosed in the IRIS Phase III clinical trial of anifrolumab in lupus nephritis (LN).